Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 281

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 281
---
 such Purchase Rights, the aggregate
Purchase Rights which such holder could have acquired if such holder had held the number of shares of Common Stock acquirable upon complete
conversion of all the Series A Preferred Stock held by such holder immediately prior to the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights at the Alternate Conversion Price (as defined
in the Series A Certificate of Designations); subject to certain limitations on beneficial ownership.

Conversion Rights

Conversion at Option of Holder. Each holder of Series A Preferred Stock may convert all, or any part, of the outstanding Series A Preferred Stock, at
any time at such holder’s option, into shares of the Common Stock (which converted shares of Common Stock are referred to as “Conversion
Shares” herein) at the fixed “Conversion Price” of $10.00, which is subject to proportional adjustment upon the occurrence
of any stock split, stock dividend, stock combination and/or similar transactions.

<div align='center'>165</div>

Voluntary Adjustment Right. Subject to the rules and regulations of the Nasdaq, we have the right, at any time, with the written consent of the Required
Holders (as defined in the Series A Certificate of Designations), to lower the fixed conversion price to any amount and for any period
of time deemed appropriate by the Board.

Alternate Conversion Upon a Triggering Event. Following the occurrence and during the continuance of a Triggering Event (as defined below), each holder
may alternatively elect to convert the Series A Preferred Stock at the “Alternate Conversion Price” equal to the lesser of:

| ● | the Conversion Price, and |

| ● | the greater of: |

| ● | the floor price of $1.00; 
 and                       |

| ● | 80% of the volume weighted                                                                                    
 average price of the Common Stock during the 5 consecutive trading days immediately prior to such conversion. |

The Series A Certificate
of Designations contains standard and customary triggering events (each, a “Series A Triggering Event”), including but not
limited to: (i) the suspension from trading or the failure to list the Common Stock within certain time periods; (ii) failure to declare
or pay any dividend when due; (iii) the failure to timely file or make effective a registration statement on Form S-1 pursuant to the
Registration Rights Agreement, dated as of February 14, 2024, by and between us and the